Literature DB >> 3355424

Further studies of the effect of vitamin D on retinoblastoma. Inhibition with 1,25-dihydroxycholecalciferol.

S M Cohen1, A M Saulenas, C R Sullivan, D M Albert.   

Abstract

We present evidence that calcitriol (1,25-dihydroxycholecalciferol) decreases tumor takes and tumor growth of subcutaneous retinoblastomas in athymic mice. Histopathologic studies showed that the calcitriol also induced necrosis of the retinoblastomas. The calcitriol, however, did not induce tumor calcification. Unfortunately, the dose of calcitriol used in this experiment caused significant toxic effects. If the toxicity of vitamin D can be alleviated without compromising its antineoplastic effect, vitamin D may be a useful chemotherapeutic agent against retinoblastoma.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3355424     DOI: 10.1001/archopht.1988.01060130587043

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

Review 1.  Vitamin D: Implications for ocular disease and therapeutic potential.

Authors:  Rose Y Reins; Alison M McDermott
Journal:  Exp Eye Res       Date:  2015-02-25       Impact factor: 3.467

2.  Transgenic models of retinoblastoma: what they tell us about its cause and treatment.

Authors:  D M Albert; A E Griep; P F Lambert; K A Howes; J J Windle; J G Lasudry
Journal:  Trans Am Ophthalmol Soc       Date:  1994

3.  Toxicity and dose-response studies of 1 alpha-hydroxyvitamin D2 in LH beta-Tag transgenic mice.

Authors:  Daniel G Dawson; Joel Gleiser; Michele L Zimbric; Soesiawaiti R Darjatmoko; Jared C Frisbie; Janice M Lokken; Mary J Lindstrom; Isabelle Audo; Stephen A Strugnell; Daniel M Albert
Journal:  Trans Am Ophthalmol Soc       Date:  2002

4.  Hydration with saline decreases toxicity of mice injected with calcitriol in preclinical studies.

Authors:  Amir A Azari; Mozhgan R Kanavi; Soesiawati R Darjatmoko; Vivian Lee; Kyungmann Kim; Heather D Potter; Daniel M Albert
Journal:  J Environ Pathol Toxicol Oncol       Date:  2013       Impact factor: 3.567

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.